FDA NDC Directory · JSON-LD · Markdown
NDC 61958-1901 · HUMAN PRESCRIPTION DRUG · TABLET
| Generic name | elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide |
|---|---|
| Labeler / Manufacturer | Gilead Sciences, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA207561 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | COBICISTAT (150 mg/1) ELVITEGRAVIR (150 mg/1) EMTRICITABINE (200 mg/1) TENOFOVIR ALAFENAMIDE FUMARATE (10 mg/1) |
| Marketing started | 20151105 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).